Diagnostic tools for arrhythmia detection in adults with congenital heart disease and heart failure

Heart Failure Clinics

Volumn 10, Issue 1, 2014, Pages 57-67

  Mondésert, Blandine ^a   Dubin, Anne M ^b   Khairy, Paul ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Adult congenital heart disease; Arrhythmias; Diagnostic testing; Electrophysiology; Heart failure

Indexed keywords

AORTA COARCTATION; CLINICAL FEATURE; CONGENITAL HEART DISEASE; DEXTROCARDIA; DIAGNOSTIC PROCEDURE; EBSTEIN ANOMALY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FALLOT TETRALOGY; HEART ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART RATE VARIABILITY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IMPLANTABLE CARDIAC MONITOR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; NON INVASIVE PROCEDURE; PACEMAKER; PATENT DUCTUS ARTERIOSUS; PULMONARY VALVE STENOSIS; QRS COMPLEX; REVIEW; SUDDEN CARDIAC DEATH; T WAVE;

ADULT CONGENITAL HEART DISEASE; ARRHYTHMIAS; DIAGNOSTIC TESTING; ELECTROPHYSIOLOGY; HEART FAILURE;

ADULT; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART DEFECTS, CONGENITAL; HEART FAILURE; HEART RATE; HUMANS; MONITORING, PHYSIOLOGIC; MYOCARDIAL CONTRACTION; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84888030526     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2013.09.009     Document Type: Review

References (59)

1. Khairy P., Ionescu-Ittu R., Mackie A.S., et al. Changing mortality in congenital heart disease. JAm Coll Cardiol 2010, 56:1149-1157.
2. Escudero C., Khairy P., Sanatani S. Electrophysiologic considerations in congenital heart disease and their relationship to heart failure. Can J Cardiol 2013, 29:821-829.
3. Oechslin E.N., Harrison D.A., Connelly M.S., et al. Mode of death in adults with congenital heart disease. AmJ Cardiol 2000, 86:1111-1116.
4. Zomer A.C., Vaartjes I., van der Velde E.T., et al. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol 2013, 168:2487-2493.
5. Nattel S., Khairy P., Schram G. Arrhythmogenic ionic remodeling: adaptive responses with maladaptive consequences. Trends Cardiovasc Med 2001, 11:295-301.
6. Walsh E.P., Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation 2007, 115:534-545.
7. Abadir S., Khairy P. Electrophysiology and adult congenital heart disease: advances and options. Prog Cardiovasc Dis 2011, 53:281-292.
8. Warnes C.A., Williams R.G., Bashore T.M., et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary. JAm Coll Cardiol 2008, 52:1890-1947.
9. Silversides C.K., Marelli A., Beauchesne L., et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol 2010, 26:143-150.
10. Khairy P., Marelli A.J. Clinical use of electrocardiography in adults with congenital heart disease. Circulation 2007, 116:2734-2746.
11. Gatzoulis M.A., Balaji S., Webber S.A., et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000, 356:975-981.
12. Khairy P., Harris L., Landzberg M.J., et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 2008, 117:363-370.
13. Schwerzmann M., Salehian O., Harris L., et al. Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. Eur Heart J 2009, 30:1873-1879.
14. Khairy P., Aboulhosn J., Gurvitz M.Z., et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 2010, 122:868-875.
15. Khairy P., Dore A., Poirier N., et al. Risk stratification in surgically repaired tetralogy of Fallot. Expert Rev Cardiovasc Ther 2009, 7:755-762.
16. Plymen C.M., Hughes M.L., Picaut N., et al. The relationship of systemic right ventricular function to ECG parameters and NT-proBNP levels in adults with transposition of the great arteries late after Senning or Mustard surgery. Heart 2010, 96:1569-1573.
17. Westhoff-Bleck M., Norozi K., Schoof S., et al. QRS duration in Fontan circulation in adults: a predictor of aerobic capacity. Int J Cardiol 2009, 132:375-381.
18. Robbins J., Nelson J.C., Rautaharju P.M., et al. The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am J Med 2003, 115:689-694.
19. Vrtovec B., Delgado R., Zewail A., et al. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 2003, 107:1764-1769.
20. Gatzoulis M.A., Till J.A., Redington A.N. Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot. The substrate for malignant ventricular tachycardia?. Circulation 1997, 95:401.
21. Berul C.I., Hill S.L., Geggel R.L., et al. Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. JCardiovasc Electrophysiol 1997, 8:1349-1356.
22. Rodriguez F.H., Moodie D.S., Neeland M., et al. Identifying arrhythmias in adults with congenital heart disease by 24-h ambulatory electrocardiography. Pediatr Cardiol 2012, 33:591-595.
23. Czosek R.J., Anderson J., Khoury P.R., et al. Utility of ambulatory monitoring in patients with congenital heart disease. Am J Cardiol 2013, 111:723-730.
24. Perloff J.K., Middlekauf H.R., Child J.S., et al. Usefulness of post-ventriculotomy signal averaged electrocardiograms in congenital heart disease. Am J Cardiol 2006, 98:1646-1651.
25. Russo G., Folino A.F., Mazzotti E., et al. Comparison between QRS duration at standard ECG and signal-averaging ECG for arrhythmic risk stratification after surgical repair of tetralogy of Fallot. JCardiovasc Electrophysiol 2005, 16:288-292.
26. Stelling J.A., Danford D.A., Kugler J.D., et al. Late potentials and inducible ventricular tachycardia in surgically repaired congenital heart disease. Circulation 1990, 82:1690.
27. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996, 93:1043-1065.
28. Massin M., von Bernuth G. Clinical and haemodynamic correlates of heart rate variability in children with congenital heart disease. Eur J Pediatr 1998, 157:967-971.
29. Aletti F., Ferrario M., de Jesus T.B., et al. Heart rate variability in children with cyanotic and acyanotic congenital heart disease: analysis by spectral and non linear indices. Conf Proc IEEE Eng Med Biol Soc 2012, 2012:4189-4192.
30. Heragu N.P., Scott W.A. Heart rate variability in healthy children and in those with congenital heart disease both before and after operation. Am J Cardiol 1999, 83:1654-1657.
31. Ohuchi H., Negishi J., Miyake A., et al. Long-term prognostic value of cardiac autonomic nervous activity in postoperative patients with congenital heart disease. Int J Cardiol 2011, 151:296-302.
32. Shah S.A., Kambur T., Chan C., et al. Relation of short-term heart rate variability to incident heart failure (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2013, 112(4):533-540. PMID: 23683953.
33. Cutler M.J., Rosenbaum D.S. Risk stratification for sudden cardiac death: is there a clinical role for T wave alternans?. Heart Rhythm 2009, 6:S56-S61.
34. Cutler M.J., Rosenbaum D.S. Explaining the clinical manifestations of T wave alternans in patients at risk for sudden cardiac death. Heart Rhythm 2009, 6:S22-S28.
35. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 2006, 114:e385-e484.
36. Alexander M.E., Cecchin F., Huang K.P., et al. Microvolt T-wave alternans with exercise in pediatrics and congenital heart disease: limitations and predictive value. Pacing Clin Electrophysiol 2006, 29:733-741.
37. Cieplucha A., Trojnarska O., Bartczak A., et al. Microvolt T wave alternans in adults with congenital heart diseases characterized by right ventricle pathology or single ventricle physiology: a case control study. BMC Cardiovasc Disord 2013, 13:26.
38. Sanatani S., Peirone A., Chiu C., et al. Use of an implantable loop recorder in the evaluation of children with congenital heart disease. Am Heart J 2002, 143:366-372.
39. Kenny D., Chakrabarti S., Ranasinghe A., et al. Single-centre use of implantable loop recorders in patients with congenital heart disease. Europace 2009, 11:303-307.
40. Ermis P., Franklin W., Kim J., et al. Electrophysiology procedures in adults with congenital heart disease. Congenit Heart Dis 2012, 7:344-348.
41. Alexander M.E., Walsh E.P., Saul J.P., et al. Value of programmed ventricular stimulation in patients with congenital heart disease. JCardiovasc Electrophysiol 1999, 10:1033-1044.
42. Khairy P., Landzberg M.J., Gatzoulis M.A., et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation 2004, 109:1994-2000.
43. Buxton A.E., Hafley G.E., Lehmann M.H., et al. Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables. Circulation 1999, 99:1843-1850.
44. Khairy P. Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective. Nat Clin Pract Cardiovasc Med 2007, 4:292-293.
45. Le Gloan L., Guerin P., Mercier L.A., et al. Clinical assessment of arrhythmias in tetralogy of Fallot. Expert Rev Cardiovasc Ther 2010, 8:189-197.
46. Khairy P., Harris L., Landzberg M.J., et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 2008, 1:250-257.
47. Mansour F., Khairy P. Programming ICDs in the modern era beyond out-of-the box settings. Pacing Clin Electrophysiol 2011, 34:506-520.
48. Wilkoff B.L., Ousdigian K.T., Sterns L.D., et al. Acomparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. JAm Coll Cardiol 2006, 48:330-339.
49. Arenal A., Ortiz M., Peinado R., et al. Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential anti-tachycardia pacing in implantable cardioverter-defibrillator patients. Heart Rhythm 2007, 4:316-322.
50. Khairy P., Mansour F. Implantable cardioverter-defibrillators in congenital heart disease: 10 programming tips. Heart Rhythm 2011, 8:480-483.
51. Dorian P., Philippon F., Thibault B., et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 2004, 1:540-547.
52. Brugada J., Mont L., Figueiredo M., et al. Enhanced detection criteria in implantable defibrillators. JCardiovasc Electrophysiol 1998, 9:261-268.
53. Ridley D.P., Gula L.J., Krahn A.D., et al. Atrial response to ventricular antitachycardia pacing discriminates mechanism of 1:1 atrioventricular tachycardia. JCardiovasc Electrophysiol 2005, 16:601-605.
54. Issa Z.F., Mansour I.N. Diagnostic value of ICD antitachycardia pacing therapy. JCardiovasc Electrophysiol 2007, 18:548-549.
55. Yu C.M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005, 112:841-848.
56. Wang L. Fundamentals of intrathoracic impedance monitoring in heart failure. Am J Cardiol 2007, 99:3G-10G.
57. van Veldhuisen D.J., Braunschweig F., Conraads V., et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 2011, 124:1719-1726.
58. Conraads V.M., Tavazzi L., Santini M., et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 2011, 32:2266-2273.
59. Lapage M.J., von Alvensleben J., Dick M., et al. Utility of intrathoracic impedance monitoring in pediatric and congenital heart disease. Pacing Clin Electrophysiol 2013, 36(8):994-999. PMID: 23594286.